Hydrochloric Acid

Hydrochloric Acid

SCHEMBL2140796

CCCC[Si](CCCC)CCCC.Cl

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.43
LMNA P02545 3/20 0.43
THRB P10828 1/20 0.40
DNM1 Q05193 7/20 0.35
ALDH1A1 P00352 4/20 0.33
TDP1 Q9NUW8 1/20 0.33
SLC22A1 O15245 2/20 0.32
SLC22A2 O15244 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HSD17B10 Q99714 1/20 0.30
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL153637 0.96 TSHR (0.46) TSHRLMNATHRBDNM1ALDH1A1
Fluoride SCHEMBL27639896 0.92 TSHR (0.43) TSHRLMNATHRBDNM1ALDH1A1
Iodide SCHEMBL20500143 0.92 TSHR (0.43) TSHRLMNATHRBDNM1ALDH1A1
Bromide SCHEMBL20500234 0.92 TSHR (0.43) TSHRLMNATHRBDNM1ALDH1A1
SCHEMBL10415306 0.89 TSHR (0.40) TSHRLMNATHRBALDH1A1TDP1
SCHEMBL16105233 0.89 TSHR (0.40) TSHRLMNATHRBALDH1A1TDP1
Hydrochloric Acid SCHEMBL20500147 0.89 TSHR (0.47) TSHRLMNATHRBDNM1ALDH1A1
Hydrochloric Acid SCHEMBL27520889 0.86 TSHR (0.38) TSHRLMNATHRBDNM1ALDH1A1
Hydrochloric Acid SCHEMBL28626607 0.86 TSHR (0.53) TSHRLMNATHRBDNM1ALDH1A1
SCHEMBL416765 0.85 TSHR (0.50) TSHRLMNATHRBDNM1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11670512-B2 Selective deposition on silicon containing surfaces VERSUM MATERIALS US, LLC (US) 2023-06-06 US claimed
US-20210118684-A1 SELECTIVE DEPOSITION ON SILICON CONTAINING SURFACES VERSUM MATERIALS US, LLC 2021-04-22 US claimed
WO-2018170382-A1 SELECTIVE DEPOSITION ON SILICON CONTAINING SURFACES VERSUM MATERIALS US, LLC (US) 2018-09-20 WO claimed
US-11670512-B2 Selective deposition on silicon containing surfaces VERSUM MATERIALS US, LLC (US) 2023-06-06 US disclosed
US-20210118684-A1 SELECTIVE DEPOSITION ON SILICON CONTAINING SURFACES VERSUM MATERIALS US, LLC 2021-04-22 US disclosed
CN-109054427-B Dye, printing ink and electrowetting display device 深圳市国华光电科技有限公司 2021-04-20 CN disclosed
WO-2018170382-A1 SELECTIVE DEPOSITION ON SILICON CONTAINING SURFACES VERSUM MATERIALS US, LLC (US) 2018-09-20 WO disclosed
US-7906682-B2 Synthesis of soluble functionalized lithium initiators THE GOODYEAR TIRE & RUBBER COMPANY (US) 2011-03-15 US disclosed
US-20100108230-A1 SYNTHESIS OF SOLUBLE FUNCTIONALIZED LITHIUM INITIATORS THE GOODYEAR TIRE & RUBBER COMPANY (US) 2010-05-06 US disclosed
US-7671237-B2 Synthesis of soluble functionalized lithium initiators THE GOODYEAR TIRE & RUBBER COMPANY (US) 2010-03-02 US disclosed
US-7166747-B2 Synthesis of soluble functionalized lithium initiators THE GOODYEAR TIRE & RUBBER COMPANY (US) 2007-01-23 US disclosed
US-20060252861-A1 Synthesis of soluble functionalized lithium initiators THE GOODYEAR TIRE & RUBBER COMPANY (US) 2006-11-09 US disclosed
US-20040097634-A1 Synthesis of soluble functionalized lithium initiators THE GOODYEAR TIRE & RUBBER COMPANY 2004-05-20 US disclosed
US-6686504-B2 COMPLEX POLYMERIZATION CATALYST THE GOODYEAR TIRE & RUBBER COMPANY 2004-02-03 US disclosed
US-6518214-B2 Organolithium compounds; soluble in aromatic hydrocarbons THE GOODYEAR TIRE & RUBBER COMPANY 2003-02-11 US disclosed
US-20020035294-A1 Synthesis of soluble functionalized lithium initiators GOODYEAR TIRE & RUBBER COMPANY, THE 2002-03-21 US disclosed
US-20020019551-A1 Synthesis of functionalized lithium initiator GOODYEAR TIRE & RUBBER COMPANY, THE 2002-02-14 US disclosed
CN-1279682-A bicyclic kinase inhibitors HOFFMANN LA ROCHE (CH) 2001-01-10 CN disclosed
US-4128606-A Impact-resistant chemically blended propylene polymer composition and process for preparation thereof MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1978-12-05 US disclosed
US-4071672-A COMPLEX CATALYST MITSUI PETROCHEMICAL INDUSTRIES LTD. (JA) 1978-01-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040097634-A1 Synthesis of soluble functionalized lithium initiators KDM5B, KDM2B, KDM5A TSHR 2536/4885LMNA 295/4885THRB 2524/4885
US-20020019551-A1 Synthesis of functionalized lithium initiator KCNMB1, TRPA1, KCNMB4 TSHR 2600/4885LMNA 276/4885THRB 1373/4885
US-20020035294-A1 Synthesis of soluble functionalized lithium initiators KDM5B, KDM2B, KDM5A TSHR 2535/4885LMNA 298/4885THRB 2524/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.